Estimates Revisions Cytosorbents Corporation
Stocks
CTSO
US23283X2062
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4383 USD | -8.11% |
|
+6.64% | -31.43% |
| 05-13 | Cytosorbents Corporation, Q1 2026 Earnings Call, May 13, 2026 | |
| 05-13 | Cytosorbents Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Stocks
- CTSO Stock
- Consensus Cytosorbents Corporation
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
